268 related articles for article (PubMed ID: 20460455)
1. Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq.
Bottomly D; Kyler SL; McWeeney SK; Yochum GS
Nucleic Acids Res; 2010 Sep; 38(17):5735-45. PubMed ID: 20460455
[TBL] [Abstract][Full Text] [Related]
2. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
3. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
4. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development.
Nateri AS; Spencer-Dene B; Behrens A
Nature; 2005 Sep; 437(7056):281-5. PubMed ID: 16007074
[TBL] [Abstract][Full Text] [Related]
5. Serial analysis of chromatin occupancy identifies beta-catenin target genes in colorectal carcinoma cells.
Yochum GS; McWeeney S; Rajaraman V; Cleland R; Peters S; Goodman RH
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3324-9. PubMed ID: 17360646
[TBL] [Abstract][Full Text] [Related]
6. A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression.
Yochum GS; Cleland R; Goodman RH
Mol Cell Biol; 2008 Dec; 28(24):7368-79. PubMed ID: 18852287
[TBL] [Abstract][Full Text] [Related]
7. Integrative ChIP-seq/microarray analysis identifies a CTNNB1 target signature enriched in intestinal stem cells and colon cancer.
Watanabe K; Biesinger J; Salmans ML; Roberts BS; Arthur WT; Cleary M; Andersen B; Xie X; Dai X
PLoS One; 2014; 9(3):e92317. PubMed ID: 24651522
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide ChIP-seq analysis of TCF4 binding regions in colorectal cancer cells.
Chen C; Lu Y; Liu J; Li L; Zhao N; Lin B
Int J Clin Exp Med; 2014; 7(11):4253-9. PubMed ID: 25550940
[TBL] [Abstract][Full Text] [Related]
9. Activation of beta-catenin signalling increases StarD7 gene expression in JEG-3 cells.
Rena V; Angeletti S; Panzetta-Dutari G; Genti-Raimondi S
Placenta; 2009 Oct; 30(10):876-83. PubMed ID: 19679347
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells.
Hatzis P; van der Flier LG; van Driel MA; Guryev V; Nielsen F; Denissov S; Nijman IJ; Koster J; Santo EE; Welboren W; Versteeg R; Cuppen E; van de Wetering M; Clevers H; Stunnenberg HG
Mol Cell Biol; 2008 Apr; 28(8):2732-44. PubMed ID: 18268006
[TBL] [Abstract][Full Text] [Related]
11. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
Takahashi M; Nakamura Y; Obama K; Furukawa Y
Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202
[TBL] [Abstract][Full Text] [Related]
12. Activation of the Wnt/β-catenin pathway represses the transcription of the β-amyloid precursor protein cleaving enzyme (BACE1) via binding of T-cell factor-4 to BACE1 promoter.
Parr C; Mirzaei N; Christian M; Sastre M
FASEB J; 2015 Feb; 29(2):623-35. PubMed ID: 25384422
[TBL] [Abstract][Full Text] [Related]
13. Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells.
Li Q; Dashwood RH
J Biol Chem; 2004 Oct; 279(44):45669-75. PubMed ID: 15331612
[TBL] [Abstract][Full Text] [Related]
14. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
15. The VTI1A-TCF4 colon cancer fusion protein is a dominant negative regulator of Wnt signaling and is transcriptionally regulated by intestinal homeodomain factor CDX2.
Davidsen J; Larsen S; Coskun M; Gögenur I; Dahlgaard K; Bennett EP; Troelsen JT
PLoS One; 2018; 13(7):e0200215. PubMed ID: 29975781
[TBL] [Abstract][Full Text] [Related]
16. The Bcl-w promoter is activated by beta-catenin/TCF4 in human colorectal carcinoma cells.
Lapham A; Adams JE; Paterson A; Lee M; Brimmell M; Packham G
Gene; 2009 Mar; 432(1-2):112-7. PubMed ID: 19124064
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
18. miR-155 Is Downregulated in Familial Adenomatous Polyposis and Modulates WNT Signaling by Targeting AXIN1 and TCF4.
Prossomariti A; Piazzi G; D'Angelo L; Miccoli S; Turchetti D; Alquati C; Montagna C; Bazzoli F; Ricciardiello L
Mol Cancer Res; 2018 Dec; 16(12):1965-1976. PubMed ID: 30072583
[TBL] [Abstract][Full Text] [Related]
19. Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.
Shitashige M; Naishiro Y; Idogawa M; Honda K; Ono M; Hirohashi S; Yamada T
Gastroenterology; 2007 Mar; 132(3):1039-54. PubMed ID: 17383426
[TBL] [Abstract][Full Text] [Related]
20. The Yin-Yang of TCF/beta-catenin signaling.
Barker N; Morin PJ; Clevers H
Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
